Related references
Note: Only part of the references are listed.A pan-NADPH Oxidase Inhibitor Ameliorates Kidney Injury in Type 1 Diabetic Rats
Debra Dorotea et al.
PHARMACOLOGY (2018)
Diabetic nephropathy in type 1 diabetes: a review of early natural history, pathogenesis, and diagnosis
Nektaria Papadopoulou-Marketou et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2017)
Visual complications in diabetes mellitus: beyond retinopathy
A. Khan et al.
DIABETIC MEDICINE (2017)
APX-115, a first-in-class pan-NADPH oxidase (Nox) inhibitor, protects db/db mice from renal injury
Jin Joo Cha et al.
LABORATORY INVESTIGATION (2017)
A novel pan-Nox inhibitor, APX-115, protects kidney injury in streptozotocin-induced diabetic mice: possible role of peroxisomal and mitochondrial biogenesis
Guideock Kwon et al.
ONCOTARGET (2017)
Diabetes and Kidney Disease: Role of Oxidative Stress
Jay C. Jha et al.
ANTIOXIDANTS & REDOX SIGNALING (2016)
NADPH Oxidase 1 Activity and ROS Generation Are Regulated by Grb2/Cbl-Mediated Proteasomal Degradation of NoxO1 in Colon Cancer Cells
Jung Hee Joo et al.
CANCER RESEARCH (2016)
Nox and renal disease
Chet E. Holterman et al.
CLINICAL SCIENCE (2015)
Therapeutic strategies of diabetic nephropathy: recent progress and future perspectives
Meng Lv et al.
DRUG DISCOVERY TODAY (2015)
Diabetic kidney disease
Merlin C. Thomas et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Targeting NADPH oxidase with a novel dual Nox1/Nox4 inhibitor attenuates renal pathology in type 1 diabetes
Yves Gorin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2015)
New Insights Into Molecular Mechanisms of Diabetic Kidney Disease
Shawn S. Badal et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2014)
Nox Enzymes and New Thinking on Reactive Oxygen: A Double-Edged Sword Revisited
J. David Lambeth et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 9 (2014)
Testosterone Stimulates Duox1 Activity through GPRC6A in Skin Keratinocytes
Eunbi Ko et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Molecular mechanisms of diabetic kidney disease
Kimberly Reidy et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Genetic Targeting or Pharmacologic Inhibition of NADPH Oxidase Nox4 Provides Renoprotection in Long-Term Diabetic Nephropathy
Jay C. Jha et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Advanced Glycation End Products and Diabetic Complications
Varun Parkash Singh et al.
KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY (2014)
NADPH oxidase-dependent redox signaling in TGF-beta-mediated fibrotic responses
Fan Jiang et al.
REDOX BIOLOGY (2014)
Unique role of NADPH oxidase 5 in oxidative stress in human renal proximal tubule cells
Peiying Yu et al.
REDOX BIOLOGY (2014)
Interaction of NADPH oxidase 1 with Toll-like receptor 2 induces migration of smooth muscle cells
Jee Hyun Lee et al.
CARDIOVASCULAR RESEARCH (2013)
Diabetic retinopathy: pathogenesis, clinical grading, management and future developments
L. Z. Heng et al.
DIABETIC MEDICINE (2013)
Diabetic Neuropathy
Aaron I. Vinik et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2013)
Renal Lesions Predict Progression of Diabetic Nephropathy in Type 1 Diabetes
M. Luiza Caramori et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
MECHANISMS OF DIABETIC COMPLICATIONS
Josephine M. Forbes et al.
PHYSIOLOGICAL REVIEWS (2013)
The Nox4 Inhibitor GKT137831 Attenuates Hypoxia-Induced Pulmonary Vascular Cell Proliferation
David E. Green et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2012)
Biochemistry, Physiology, and Pathophysiology of NADPH Oxidases in the Cardiovascular System
Bernard Lassegue et al.
CIRCULATION RESEARCH (2012)
Paraoxonase 2 decreases renal reactive oxygen species production, lowers blood pressure, and mediates dopamine D2 receptor-induced inhibition of NADPH oxidase
Yu Yang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Nicotinamide Adenine Dinucleotide Phosphate Oxidase in Experimental Liver Fibrosis: GKT137831 as a Novel Potential Therapeutic Agent
Tomonori Aoyama et al.
HEPATOLOGY (2012)
Glomerular hyperfiltration: a marker of early renal damage in pre-diabetes and pre-hypertension
Paolo Palatini
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Aiding and abetting roles of NOX oxidases in cellular transformation
Karen Block et al.
NATURE REVIEWS CANCER (2012)
Design, synthesis and biological activity of original pyrazolo-pyrido-diazepine, -pyrazine and -oxazine dione derivatives as novel dual Nox4/Nox1 inhibitors
Francesca Gaggini et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Regulation of reactive oxygen species generation in cell signaling
Yun Soo Bae et al.
MOLECULES AND CELLS (2011)
Role of LOX-1 in Ang II-induced oxidative functional damage in renal tubular epithelial cells
Yanfang Xu et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2010)
First in Class, Potent, and Orally Bioavailable NADPH Oxidase Isoform 4 (Nox4) Inhibitors for the Treatment of Idiopathic Pulmonary Fibrosis
Benoit Laleu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Pathologic Classification of Diabetic Nephropathy
Thijs W. Cohen Tervaert et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Regulation of NOXO1 Activity through Reversible Interactions with p22phox and NOXA1
Sujit Dutta et al.
PLOS ONE (2010)
KDOQI in the Era of Global Guidelines
Michael V. Rocco et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2009)
Targeting and Regulation of Reactive Oxygen Species Generation by Nox Family NADPH Oxidases
Thomas L. Leto et al.
ANTIOXIDANTS & REDOX SIGNALING (2009)
Mechanisms of Vascular Smooth Muscle NADPH Oxidase 1 (Nox1) Contribution to Injury-Induced Neointimal Formation
Moo Yeol Lee et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Poldip2, a Novel Regulator of Nox4 and Cytoskeletal Integrity in Vascular Smooth Muscle Cells
Alicia N. Lyle et al.
CIRCULATION RESEARCH (2009)
Structure, regulation and evolution of Nox-family NADPH oxidases that produce reactive oxygen species
Hideki Sumimoto
FEBS JOURNAL (2008)
Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-α-dependent pathway
Vicki Thallas-Bonke et al.
DIABETES (2008)
Mechanism of angiotensin II-induced superoxide production in cells reconstituted with angiotensin type 1 receptor and the components of NADPH oxidase
Hyun Choi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Nox1 mediates basic fibroblast growth factor-induced migration of vascular smooth muscle cells
Katrin Schroeder et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Diabetic neuropathy - a review
Gerard Said
NATURE CLINICAL PRACTICE NEUROLOGY (2007)
The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology
Karen Bedard et al.
PHYSIOLOGICAL REVIEWS (2007)
The burden of chronic kidney disease in Australian patients with type 2 diabetes (the NEFRON study)
Merlin C. Thomas et al.
MEDICAL JOURNAL OF AUSTRALIA (2006)
Nox1-dependent reactive oxygen generation is regulated by Rac1
Guangjie Cheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Involvement of Rac1 in activation of multicomponent Nox1- and Nox3-based NADPH oxidases
T Ueyama et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Molecular interaction of NADPH oxidase 1 with βPix and nox organizer 1
HS Park et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Regulation of the phagocyte NADPH oxidase by Rac GTPase
Gary M. Bokoch et al.
ANTIOXIDANTS & REDOX SIGNALING (2006)
Point mutations in the proline-rich region of p22phox are dominant inhibitors of Nox1- and Nox2-dependent reactive oxygen generation
T Kawahara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Dual oxidase-2 has an intrinsic Ca2+-dependent H2O2-generating activity
R Ameziane-El-Hassani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The NADPH oxidase Nox3 constitutively produces superoxide in a p22Phox-dependent manner
N Ueno et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Mechanism of Ca2+ activation of the NADPH oxidase 5 (NOX5)
B Bánfi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Characterization of superoxide-producing sites in isolated brain mitochondria
AP Kudin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Nox3 regulation by NOXO1, p47phox, and p67phox
GJ Cheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
NOX3, a superoxide-generating NADPH oxidase of the inner ear
B Bánfi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Role of advanced glycation end products in diabetic nephropathy
JM Forbes et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Proteins homologous to p47phox and p67phox support superoxide production by NAD(P)H oxidase 1 in colon epithelial cells
M Geiszt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Molecular basis of phosphorylation-induced activation of the NADPH oxidase
Y Groemping et al.
CELL (2003)
Extracellular matrix metabolism in diabetic nephropathy
RM Mason et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Role of oxidative stress in advanced glycation end product-induced mesangial cell activation
MA Lal et al.
KIDNEY INTERNATIONAL (2002)
Upregulation of the vascular NAD(P)H-oxidase isoforms Nox1 and Nox4 by the renin-angiotensin system in vitro and in vivo
M Wingler et al.
FREE RADICAL BIOLOGY AND MEDICINE (2001)
A Ca2+-activated NADPH oxidase in testis, spleen, and lymph nodes
B Bánfi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Novel gp91phox homologues in vascular smooth muscle cells -: Nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways
B Lassègue et al.
CIRCULATION RESEARCH (2001)
NADPH oxidase subunit, gp91phox homologue, preferentially expressed in human colon epithelial cells
H Kikuchi et al.
GENE (2000)
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
T Nishikawa et al.
NATURE (2000)
Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes
D Koya et al.
FASEB JOURNAL (2000)
Prevention of albuminuria by aminoguanidine or ramipril in streptozotocin-induced diabetic rats is associated with the normalization of glomerular protein kinase C
TM Osicka et al.
DIABETES (2000)